MMPJOE, a few constructive thoughts on the relationship

New Post Public Reply Private Reply Replies (1) Message Board
Buildit
414
MMPJOE, a few constructive thoughts on the relationship between you and this board:

1) This board is NOT the Yahoo Message board. The vast majority of the posters here are 100% wanting to see success for you and Generex. Yes, that includes Docj as well.

While there may be an occasional snarky post that you find offensive, if you click on any of our names and read a bunch of posts by any one individual, you will see that we are just trying to sort through the complex world of Generex and watch over our investments. And from time to time there is skepticism or frustration. That is acceptable, if expressed respectfully, and that is how we try to keep it.

A few digs every now and then slip out, but don't waste energy screaming at the choir. We are on your team, Joe.

2) I posted an analogy here a while ago about your GNBT knowledge vs. ours. I'll throw out another.

Imagine you are a Calculus professor at a university that has decided to go teach 4th grade math. There is so much knowledge in your head that you can't imagine how little your students know or remember what it was like to learn multiplication and division. And while you are teaching these simple topics, your head is swimming with all the advanced topics you'd like your students to learn, the advanced applications for them, etc.

Similarly, you have all the details of all things Generex in your head. I can certainly understand that you could get frustrated with us. Most of us simply don't have as much knowledge and understanding of the details of filings, listing requirements, market makers, various capital vehicles, company structures, and, of course, Generex in our heads.

On top of that, there is simply so much to absorb and keep straight, and there are many things you can't reveal to us, especially in a place like this or at a time that we'd like to know it.

But we sure are putting in an effort, and being here exchanging thoughts is one of the ways we do that. Please try to keep that in mind.

3) Things change, and we don't always receive/process/remember the latest info. I think the S-1 MIGHT be a good example. Our collective understanding of the process for raising the $40MM before the last conference call was that the S-1 could be priced at any time (after all approvals), using the share price from 5 consecutive trading days chosen by you; but the catch was that the 5 days you chose would be used for the entire $40MM. It was a one-shot deal.

That has been the source of much stress with this group, as it has seemed to us that you would not be able to pull a single cent out until there was a 5-day share price stretch that would make sense to raise the entire $40MM. It seemed like such a time was pretty far off, and we would be caught between massive dilution and a long timeline.

On the last call, you made it clear that the $40MM would act more like a line of credit. So you could pull part of it out soon, get the wheels turning a little more, pull more out later when the share price is more favorable, repeat as necessary...

What a revelation! I think there was a collective sigh here when that was understood.

As I said this MIGHT be an example of point #3... I believe this is a change from the way the S-1 was set up originally. Maybe I'm wrong. If that isn't the case, then it is an example of point #2: This knowledge was in your head as a basic assumption of how this funding would work, so it was never conveyed to us explicitly.

Either way, none of us understood until the last call that this was how the funding would work, but we are VERY excited to gain that understanding.


Anyway, we do appreciate the hard work you and all the Generex team have been doing. Most of us feel like we are very close to seeing your plan come together, and we are excited to see how it all plays out in the next month or two. If all goes well during that time period, a lot of stress will hopefully come off your shoulders... and ours as well.

We wish you luck putting the final pieces of this phase together, and we welcome you to come back and have meaningful conversations if you think you can add to them in this unofficial forum.

Thanks, Joe! Have a great week!

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Eagle Bank Club Breathing New Life Into Historic Site

Updated Category News Views 22

Preserving History with Contemporary Flair Sometimes, a building is more than just bricks and mortar, it's the heart of a community's memories. Come spring 2027, Eagle Bank Club is set to throw open its doors, reviving the century-old tradition of gathering in a place that's been etched into the town's identity. Scott Slater and Todd Ketlinski aren't just opening another...

Continue Reading
AION Labs Elevates Leadership, Eyes New R&D Horizons

Updated Category News Views 70

Setting New Standards in Pharma Innovation The air in Rehovot, Israel might be filled with more than just technological aspirations, thanks to AION Labs stepping up its leadership game. This venture studio doesn't seem content to rest on its laurels. Nope, it's diving headlong into the deeper end of pharma R&D, scouting out fresh tech territories like quantum computing...

Continue Reading
Kia's Landmark Triple Win at 2026 Car Awards

Updated Category News Views 85

Kia Makes History Well, folks, Kia has pulled off what many might have thought impossible. They snagged not one, not two, but three of Germany's Golden Steering Wheel awards. That's a real hat trick and a first for any non-European auto brand. With competition hotter than a stolen Tesla, Kia's not just keeping pace but setting it. The Golden Steering Wheel is one of those...

Continue Reading
Yiddish Prescription Labels Extend Language Access in NY

Updated Category News Views 92

Here's something that might fly under the radar unless you're really in tune with how language impacts healthcare—RxTran's move to include Yiddish on prescription labels might not be rocking financial markets, but it's got a punchy little implication for those of us watching where healthcare intersects with real-world needs. A Push Toward Accessibility Healthcare...

Continue Reading
Fibocom & GridCrest Unveil Smart Meter Tech at Enlit

Updated Category News Views 60

A Bright Future for Smart Meter Technology Revealed Some days look drearier than others in the tech game, but not this one. Fibocom and GridCrest just showcased their latest collaboration at Enlit Europe 2026 in Vienna, and it paints a pretty sparkling future for smart electricity meters. We're talking about the ME260 single-phase smart meter that promises to be a...

Continue Reading
Denver's Holiday Extravaganza: Lights, Markets, and More!

Updated Category News Views 35

Stepping into Denver's Holiday Magic The holiday spirit descends upon Denver like clockwork each year, and 2026 is no exception—a short drive or flight drops you into a winter wonderland packed with more lights, markets, and cheer than you can shake a sleigh bell at. Visitors and locals alike have a smorgasbord of options to revel in. The Mile High Tree and Drone Shows:...

Continue Reading
myKaarma's Off-Site Wash: A Game Changer for Dealers

Updated Category News Views 37

myKaarma Offers Time and Convenience Boost with Wash Option When was the last time a car dealership didn't have folks lined up waiting for a wash? Dragging out your car's service longer than a Sunday sermon. But today, myKaarma, the folks behind dealership customer interaction magic, cracked open another bottle of convenience with their latest offering: off-site,...

Continue Reading
Dixie Group Gears Up for Q3 Earnings Call Reveal

Updated Category News Views 153

Anticipation Builds for The Dixie Group's Q3 Results Ah, the smell of anticipation in the air—it's earnings season again, folks! For those keeping a keen eye, The Dixie Group, Inc. (OTCQB: DXYN) sets the stage for the big unveil of its 2026 third-quarter results. They're rolling out the red carpet for investors on Thursday, November 12, 2026, at 11:30 a.m. Eastern Time,...

Continue Reading
Portable Tombstone Urn: A Shift in Memorial Traditions

Updated Category News Views 107

An Uncommon Approach to Remembering Loved Ones Read this on a plane, in a crowded office, or in a graveyard—doesn't matter. The heart of human stories lies buried in traditions. But here's one: portable tombstones, shake things up more than Aunt Edna’s offbeat “nonalcoholic” eggnog. This time, it's not about the latest market tickers or skyrocketing stock but...

Continue Reading
Trimble Revamps SketchUp: Game-Changing Design Innovations

Updated Category News Views 60

Breaking Down Trimble's Latest Moves in Design Software The design world spins on innovation, and Trimble's pushing the boat out with SketchUp 2027. Unveiled at the swanky Trimble Dimensions User Conference in Las Vegas, this revamp is all about smashing through workflow barriers that have tripped up designers for too long. If you've ever haggled with clunky model...

Continue Reading

Top 5 Most Recently Viewed Articles

Tech Stocks' Recovery Boosts US Market Outlook Amid Job Data

Updated Category News Views 287

US Stock Futures Steady After Tech Gains U.S. stock index futures showed stability recently, following a robust performance on Wall Street primarily fueled by technology stocks. Investors are now keenly focused on the upcoming jobs data that is set to be released shortly. The S&P 500 Futures are hovering around 5,991.00 points, while Nasdaq 100 Futures experienced a...

Continue Reading
Understanding the Surge in CACI International's Short Interest

Updated Category News Views 147

Understanding the Surge in CACI International's Short Interest CACI International Inc (NYSE: CACI) has recently seen a notable increase in its short percent of float, now standing at 20.91%. According to the latest figures, there are approximately 794 thousand shares sold short, representing 3.99% of all available shares for trading. This data suggests that based on the...

Continue Reading
Calidi Biotherapeutics Unveils Q3 Financials and Innovations

Updated Category News Views 151

Calidi Biotherapeutics Shares Q3 2025 Financial Results Calidi Biotherapeutics Inc. (NYSE American: CLDI), a groundbreaking biotechnology company, has recently shared its financial outcomes and pivotal developments from the third quarter of 2025. With a mission to enhance targeted therapies that deliver genetic medicines, Calidi is achieving significant progress through...

Continue Reading
SBM Offshore Shares Buyback Program Progress Report

Updated Category News Views 184

SBM Offshore's Share Repurchase Program Overview SBM Offshore has recently shared commendable progress regarding its share repurchase program, highlighting transactions made under its EUR130 million (approximately US$140 million) initiative from October 17 to October 23. The company has a clear goal of optimizing its share capital while ensuring vital shares are available...

Continue Reading
Papa John's Faces Securities Lawsuit Amid 17.18% Stock Drop

Updated Category News Views 60

Papa John's Legal Trouble and Stock Tumble Lemme paint you a picture: Papa John's International, Inc. just walked smack dab into the middle of a courtroom drama it's not too eager to star in. The lawsuit's hot on their trail after a sharp 17.18% plummet in their stock price. As far as the markets go, that's a nosedive that'll smack the paint off any seasoned investor's...

Continue Reading